Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis

Background: Platinum-based agents, including cisplatin, carboplatin, and oxaliplatin, are indispensable for the treatment of lung cancer. The development of toxicity frequently necessitates dose reduction or discontinuation of therapy, despite the clinical response. Pharmacogenomics studies were rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenhui, Wang, Ying, Luo, Jianquan, Yuan, Haiyan, Luo, Zhiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090160/
https://www.ncbi.nlm.nih.gov/pubmed/32257953
http://dx.doi.org/10.3389/fonc.2019.01573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090160/
https://www.ncbi.nlm.nih.gov/pubmed/32257953
http://dx.doi.org/10.3389/fonc.2019.01573

Ejemplares similares